Breaking News Instant updates and real-time market news.

PG

Procter & Gamble

$139.37 /

+0.6 (+0.43%)

06:57
07/30/21
07/30
06:57
07/30/21
06:57

Procter & Gamble reports Q4 core EPS $1.13, consensus $1.09

Reports Q4 revenue $18.9B, consensus $18.36B. Excluding the impacts of foreign exchange, acquisitions and divestitures, organic sales increased four percent, driven by a one percent increase in shipment volume, a one percent increase in pricing and positive mix impact of one percent.

  • 30

    Jul

PG Procter & Gamble
$139.37 /

+0.6 (+0.43%)

06/23/21 UBS
Procter & Gamble initiated with a Neutral at UBS
04/21/21
Fly Intel: Top five analyst downgrades
04/21/21 Roth Capital
PureCycle Technologies initiated with a Buy at Roth Capital
04/21/21 Citi
Procter & Gamble downgraded to Neutral from Buy at Citi

TODAY'S FREE FLY STORIES

Earnings
Old Dominion reports Q3 EPS $2.47, consensus $2.37 » 07:22
10/27/21
10/27
07:22
10/27/21
07:22
ODFL

Old Dominion

$326.00 /

+1.47 (+0.45%)

Reports Q3 revenue $1.4B,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ODFL Old Dominion
$326.00 /

+1.47 (+0.45%)

ODFL Old Dominion
$326.00 /

+1.47 (+0.45%)

10/19/21 BofA
Old Dominion price target raised to $300 from $250 at BofA
10/07/21 Citi
Old Dominion price target raised to $295 from $280 at Citi
09/29/21 Raymond James
Old Dominion price target raised to $315 from $280 at Raymond James
09/02/21 KeyBanc
Old Dominion price target raised to $310 from $300 at KeyBanc
ODFL Old Dominion
$326.00 /

+1.47 (+0.45%)

Hot Stocks
McDonald's reports Q3 U.S. SSS up 9.6%, up 14.6% on two-year basis » 07:22
10/27/21
10/27
07:22
10/27/21
07:22
MCD

McDonald's

$236.38 /

-0.96 (-0.40%)

International Operated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MCD McDonald's
$236.38 /

-0.96 (-0.40%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

10/14/21 Wells Fargo
McDonald's price target raised to $276 from $269 at Wells Fargo
10/05/21 Loop Capital
McDonald's initiated with a Buy at Loop Capital
10/05/21 Deutsche Bank
McDonald's price target raised to $265 ahead of Q3 at Deutsche Bank
10/05/21 Piper Sandler
Piper teen survey shows clothing outranked food for first time since 2014
MCD McDonald's
$236.38 /

-0.96 (-0.40%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

MCD McDonald's
$236.38 /

-0.96 (-0.40%)

Hot Stocks
HCW Biologics announces appointment of two new members to board » 07:22
10/27/21
10/27
07:22
10/27/21
07:22
HCWB

HCW Biologics

$2.71 /

-0.065 (-2.35%)

HCW Biologics announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCWB HCW Biologics
$2.71 /

-0.065 (-2.35%)

HCWB HCW Biologics
$2.71 /

-0.065 (-2.35%)

  • 20
    Jul
HCWB HCW Biologics
$2.71 /

-0.065 (-2.35%)

Recommendations
'Not a picture postcard quarter' for Microsoft, but close enough, says Bernstein » 07:21
10/27/21
10/27
07:21
10/27/21
07:21
MSFT

Microsoft

$309.74 /

+1.31 (+0.42%)

Bernstein analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

07:19 Today Goldman Sachs
Microsoft price target raised to $400 from $360 at Goldman Sachs
07:03 Today Citi
Microsoft price target raised to $407 from $384 at Citi
06:58 Today Barclays
Microsoft price target raised to $363 from $345 at Barclays
06:39 Today Mizuho
Microsoft price target raised to $360 from $350 at Mizuho
MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

Hot Stocks
Colliers to acquire controlling interest in Colliers International Italia » 07:21
10/27/21
10/27
07:21
10/27/21
07:21
CIGI

Colliers International

$146.34 /

+1.665 (+1.15%)

Colliers announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CIGI Colliers International
$146.34 /

+1.665 (+1.15%)

CIGI Colliers International
$146.34 /

+1.665 (+1.15%)

10/26/21 RBC Capital
Colliers International price target raised to $185 from $160 at RBC Capital
10/14/21 Scotiabank
Colliers price target raised to $165 from $152 at Scotiabank
02/16/21 TD Securities
Colliers International price target raised to $125 from $100 at TD Securities
02/16/21 RBC Capital
Colliers International price target raised to $126 from $96 at RBC Capital
CIGI Colliers International
$146.34 /

+1.665 (+1.15%)

CIGI Colliers International
$146.34 /

+1.665 (+1.15%)

Hot Stocks
Rockwell Automation enters five-year agreement with The Pyure Company » 07:21
10/27/21
10/27
07:21
10/27/21
07:21
ROK

Rockwell Automation

$315.56 /

+0.37 (+0.12%)

Rockwell Automation and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ROK Rockwell Automation
$315.56 /

+0.37 (+0.12%)

ROK Rockwell Automation
$315.56 /

+0.37 (+0.12%)

10/07/21 Wells Fargo
Wells Fargo starts Rockwell Automation at Underweight on 'rich' valuation
10/07/21 Wells Fargo
Rockwell Automation initiated with an Underweight at Wells Fargo
10/05/21
Fly Intel: Top five analyst initiations
10/05/21 Argus
Rockwell Automation initiated with a Buy at Argus
ROK Rockwell Automation
$315.56 /

+0.37 (+0.12%)

ROK Rockwell Automation
$315.56 /

+0.37 (+0.12%)

Hot Stocks
Kymera Therapeutics presents data on KT-474 Phase 1 trial » 07:20
10/27/21
10/27
07:20
10/27/21
07:20
KYMR

Kymera Therapeutics

$56.41 /

+1.19 (+2.16%)

Kymera Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

10/13/21 Brookline
Kymera Therapeutics initiated with Buy, $80 target at Brookline
10/12/21 Brookline
Kymera Therapeutics initiated with a Buy at Brookline
09/30/21 B. Riley
Kymera Therapeutics initiated with Neutral on valuation at B. Riley
09/30/21 B. Riley
Kymera Therapeutics initiated with a Neutral at B. Riley
KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

  • 01
    Jul
KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

KYMR Kymera Therapeutics
$56.41 /

+1.19 (+2.16%)

Hot Stocks
Rise Education receives preliminary non-binding acquisition proposal » 07:20
10/27/21
10/27
07:20
10/27/21
07:20
REDU

Rise Education

$1.26 /

-0.22 (-14.86%)

Rise Education has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
REDU Rise Education
$1.26 /

-0.22 (-14.86%)

REDU Rise Education
$1.26 /

-0.22 (-14.86%)

06/30/21 Credit Suisse
Rise Education downgraded to Neutral from Outperform at Credit Suisse
REDU Rise Education
$1.26 /

-0.22 (-14.86%)

Earnings
Silgan Holdings tightens FY21 adjusted EPS view to $3.30-$3.40 from $3.30-$3.45 » 07:19
10/27/21
10/27
07:19
10/27/21
07:19
SLGN

Silgan Holdings

$39.16 /

-0.15 (-0.38%)

Consensus $3.39.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

10/05/21 Loop Capital
Loop starts Silgan with Buy amid 'meaningful growth' in North America
10/05/21 Loop Capital
Silgan Holdings initiated with a Buy at Loop Capital
10/01/21 JPMorgan
JPMorgan downgrades Silgan to sell on food can demand concerns
10/01/21 JPMorgan
Silgan Holdings downgraded to Underweight from Neutral at JPMorgan
SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

Hot Stocks
In8bio announces publication of preclinical results on INB-200 with temozolomide » 07:19
10/27/21
10/27
07:19
10/27/21
07:19
INAB

In8bio

$6.37 /

+0.01 (+0.16%)

IN8bio announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
INAB In8bio
$6.37 /

+0.01 (+0.16%)

INAB In8bio
$6.37 /

+0.01 (+0.16%)

08/24/21 Mizuho
In8bio initiated with a Buy at Mizuho
08/23/21 B. Riley
In8bio initiated with a Buy on cancer potential at B. Riley
08/23/21 B. Riley
In8bio initiated with a Buy at B. Riley
  • 30
    Jul
  • 13
    Nov
INAB In8bio
$6.37 /

+0.01 (+0.16%)

Earnings
Hayward raises FY21 revenue growth view to 59%-62% from 54%-58% » 07:19
10/27/21
10/27
07:19
10/27/21
07:19
HAYW

Hayward

$24.56 /

-0.275 (-1.11%)

FY21 consensus $1.37B.…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAYW Hayward
$24.56 /

-0.275 (-1.11%)

HAYW Hayward
$24.56 /

-0.275 (-1.11%)

09/16/21 William Blair
Hayward shares have 50% upside to $30, says William Blair
06/09/21 BMO Capital
Hayward initiated with a Market Perform at BMO Capital
05/06/21 KeyBanc
Hayward price target raised to $28 from $21 at KeyBanc
05/06/21 Morgan Stanley
Hayward price target raised to $27 from $19 at Morgan Stanley
HAYW Hayward
$24.56 /

-0.275 (-1.11%)

  • 12
    Mar
HAYW Hayward
$24.56 /

-0.275 (-1.11%)

Earnings
Silgan Holdings sees Q4 adjusted EPS 69c-79c, consensus 74c » 07:19
10/27/21
10/27
07:19
10/27/21
07:19
SLGN

Silgan Holdings

$39.16 /

-0.15 (-0.38%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

10/05/21 Loop Capital
Loop starts Silgan with Buy amid 'meaningful growth' in North America
10/05/21 Loop Capital
Silgan Holdings initiated with a Buy at Loop Capital
10/01/21 JPMorgan
JPMorgan downgrades Silgan to sell on food can demand concerns
10/01/21 JPMorgan
Silgan Holdings downgraded to Underweight from Neutral at JPMorgan
SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

Recommendations
Microsoft price target raised to $400 from $360 at Goldman Sachs » 07:19
10/27/21
10/27
07:19
10/27/21
07:19
MSFT

Microsoft

$309.74 /

+1.31 (+0.42%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

07:03 Today Citi
Microsoft price target raised to $407 from $384 at Citi
06:58 Today Barclays
Microsoft price target raised to $363 from $345 at Barclays
06:39 Today Mizuho
Microsoft price target raised to $360 from $350 at Mizuho
06:06 Today Piper Sandler
Microsoft price target raised to $352 from $310 at Piper Sandler
MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

MSFT Microsoft
$309.74 /

+1.31 (+0.42%)

Earnings
Blackstone Mortgage reports Q3 EPS 63c, consensus 61c » 07:18
10/27/21
10/27
07:18
10/27/21
07:18
BXMT

Blackstone Mortgage

$32.51 /

-0.285 (-0.87%)

Blackstone Mortgage Trust…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BXMT Blackstone Mortgage
$32.51 /

-0.285 (-0.87%)

BXMT Blackstone Mortgage
$32.51 /

-0.285 (-0.87%)

04/29/21 Wells Fargo
Blackstone Mortgage price target raised to $36 from $30 at Wells Fargo
04/26/21 JPMorgan
Blackstone Mortgage downgraded to Neutral from Overweight at JPMorgan
04/26/21 JPMorgan
Blackstone Mortgage downgraded to Neutral from Overweight at JPMorgan
04/13/21 BTIG
Blackstone Mortgage initiated with a Buy at BTIG
BXMT Blackstone Mortgage
$32.51 /

-0.285 (-0.87%)

  • 10
    Sep
Earnings
Hayward reports Q3 EPS 21c, consensus 23c » 07:18
10/27/21
10/27
07:18
10/27/21
07:18
HAYW

Hayward

$24.56 /

-0.275 (-1.11%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HAYW Hayward
$24.56 /

-0.275 (-1.11%)

HAYW Hayward
$24.56 /

-0.275 (-1.11%)

09/16/21 William Blair
Hayward shares have 50% upside to $30, says William Blair
06/09/21 BMO Capital
Hayward initiated with a Market Perform at BMO Capital
05/06/21 KeyBanc
Hayward price target raised to $28 from $21 at KeyBanc
05/06/21 Morgan Stanley
Hayward price target raised to $27 from $19 at Morgan Stanley
HAYW Hayward
$24.56 /

-0.275 (-1.11%)

  • 12
    Mar
HAYW Hayward
$24.56 /

-0.275 (-1.11%)

Hot Stocks
Adagene establishes collaborations for trial of ADG106 » 07:18
10/27/21
10/27
07:18
10/27/21
07:18
ADAG

Adagene

$11.52 /

-0.29 (-2.46%)

Adagene, the National…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ADAG Adagene
$11.52 /

-0.29 (-2.46%)

ADAG Adagene
$11.52 /

-0.29 (-2.46%)

06/25/21
Fly Intel: Top five analyst initiations
06/25/21 China Renaissance
Adagene initiated with a Buy, $40.57 target at China Renaissance
06/24/21 China Renaissance
Adagene initiated with a Buy at China Renaissance
03/08/21 Jefferies
Adagene initiated with a Buy at Jefferies
ADAG Adagene
$11.52 /

-0.29 (-2.46%)

  • 09
    Feb
Downgrade
UPS downgraded to Hold from Buy at Loop Capital » 07:18
10/27/21
10/27
07:18
10/27/21
07:18
UPS

UPS

$218.16 /

+14.15 (+6.94%)

Loop Capital analyst Rick…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
UPS UPS
$218.16 /

+14.15 (+6.94%)

UPS UPS
$218.16 /

+14.15 (+6.94%)

10/14/21
Fly Intel: Top five analyst upgrades
10/14/21 Stifel
UPS upgraded to Buy from Hold at Stifel
10/13/21 Stifel
UPS upgraded to Buy from Hold at Stifel
09/28/21
Fly Intel: Top five analyst initiations
UPS UPS
$218.16 /

+14.15 (+6.94%)

UPS UPS
$218.16 /

+14.15 (+6.94%)

UPS UPS
$218.16 /

+14.15 (+6.94%)

UPS UPS
$218.16 /

+14.15 (+6.94%)

Recommendations
NCR Corp. price target lowered to $54 from $59 at RBC Capital » 07:17
10/27/21
10/27
07:17
10/27/21
07:17
NCR

NCR Corp.

$41.51 /

-0.905 (-2.13%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

08/04/21 Morgan Stanley
Morgan Stanley trims NCR Corp. price target to $61, says 'buy the dip'
08/04/21 RBC Capital
NCR Corp. price target raised to $59 from $47 at RBC Capital
06/10/21 Morgan Stanley
Seagate, Dell, NCR, NetApp top picks in IT Hardware at Morgan Stanley
05/10/21 Morgan Stanley
NCR Corp. price target raised to $62 from $53 at Morgan Stanley
NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

NCR NCR Corp.
$41.51 /

-0.905 (-2.13%)

Hot Stocks
Else Nutrition announces performance results on Amazon » 07:17
10/27/21
10/27
07:17
10/27/21
07:17
BABYF

Else Nutrition

$1.40 /

+ (+0.00%)

, AMZN

Amazon.com

$3,376.16 /

+57.2 (+1.72%)

ELSE NUTRITION HOLDINGS…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BABYF Else Nutrition
$1.40 /

+ (+0.00%)

AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

BABYF Else Nutrition
$1.40 /

+ (+0.00%)

05/03/21 Canaccord
Else Nutrition price target lowered to C$5.75 from C$6.50 at Canaccord
12/07/20 Canaccord
Else Nutrition initiated with a Speculative Buy at Canaccord
AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

10/25/21 Wedbush
E-commerce share gains, advertiser demand to drive Amazon Q3 beat, says Wedbush
10/22/21 Credit Suisse
Amazon price target lowered to $4,200 from $4,700 at Credit Suisse
10/21/21 Baird
Amazon executive commentary on supply chain 'largely positive,' says Baird
10/21/21 Oppenheimer
Activision Blizzard price target lowered to $100 from $105 at Oppenheimer
AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

AMZN Amazon.com
$3,376.16 /

+57.2 (+1.72%)

Earnings
Silgan Holdings reports Q3 adjusted EPS $1.02, consensus $1.04 » 07:17
10/27/21
10/27
07:17
10/27/21
07:17
SLGN

Silgan Holdings

$39.16 /

-0.15 (-0.38%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

10/05/21 Loop Capital
Loop starts Silgan with Buy amid 'meaningful growth' in North America
10/05/21 Loop Capital
Silgan Holdings initiated with a Buy at Loop Capital
10/01/21 JPMorgan
JPMorgan downgrades Silgan to sell on food can demand concerns
10/01/21 JPMorgan
Silgan Holdings downgraded to Underweight from Neutral at JPMorgan
SLGN Silgan Holdings
$39.16 /

-0.15 (-0.38%)

Recommendations
Google wins 'hide and seek,' says Bernstein » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
GOOGL

Alphabet Class A

$2,784.05 /

+39.3 (+1.43%)

, GOOG

Alphabet

$2,794.00 /

+22.64 (+0.82%)

, AAPL

Apple

$149.26 /

+0.6 (+0.40%)

, SNAP

Snap

$55.40 /

+0.925 (+1.70%)

, FB

Facebook

$315.80 /

-12.86 (-3.91%)

Bernstein analyst Mark…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

07:11 Today Canaccord
Alphabet price target raised to $3350 from $3100 at Canaccord
06:55 Today Barclays
Alphabet price target raised to $3,300 from $3,200 at Barclays
06:38 Today Mizuho
Alphabet price target raised to $3,350 from $3,100 at Mizuho
06:16 Today JMP Securities
Alphabet Class A price target raised to $3,300 from $3,100 at JMP Securities
GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

06:55 Today Barclays
Alphabet price target raised to $3,300 from $3,200 at Barclays
06:38 Today Mizuho
Alphabet price target raised to $3,350 from $3,100 at Mizuho
06:09 Today Piper Sandler
Alphabet price target raised to $3,150 from $3,034 at Piper Sandler
10/26/21 Morgan Stanley
Facebook price target lowered to $365 from $400 at Morgan Stanley
AAPL Apple
$149.26 /

+0.6 (+0.40%)

07:15 Today Canaccord
Twitter price target lowered to $72 from $78 at Canaccord
07:14 Today Bernstein
Twitter reports 'clean quarter,' says Bernstein
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
SNAP Snap
$55.40 /

+0.925 (+1.70%)

10/26/21 Wedbush
Facebook price target lowered to $325 from $355 at Wedbush
10/26/21 Wells Fargo
Facebook price target lowered to $425 from $450 at Wells Fargo
10/24/21 BofA
Snap price target lowered to $67 from $80 at BofA
10/22/21 RBC Capital
Snap price target lowered to $70 from $88 at RBC Capital
FB Facebook
$315.80 /

-12.86 (-3.91%)

10/26/21
Fly Intel: Top five analyst upgrades
10/26/21 Truist
Facebook price target lowered to $400 from $425 at Truist
10/26/21 Oppenheimer
Oppenheimer keeps Outperform, $405 target on Facebook after quarterly results
10/26/21 Monness Crespi
Facebook price target lowered to $460 from $500 at Monness Crespi
GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

GOOG Alphabet
$2,794.00 /

+22.64 (+0.82%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

GOOGL Alphabet Class A
$2,784.05 /

+39.3 (+1.43%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

SNAP Snap
$55.40 /

+0.925 (+1.70%)

FB Facebook
$315.80 /

-12.86 (-3.91%)

AAPL Apple
$149.26 /

+0.6 (+0.40%)

Earnings
Acceleron expects Q3 royalty revenue of approximately $32M from Reblozy » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
XLRN

Acceleron

$173.85 /

+0.23 (+0.13%)

, BMY

Bristol-Myers

$58.24 /

+0.47 (+0.81%)

Acceleron Pharma (XLRN) …

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

10/06/21 Jefferies
Acceleron initiated with a Hold at Jefferies
10/04/21 Raymond James
Acceleron downgraded to Market Perform from Strong Buy at Raymond James
10/01/21 Barclays
Acceleron downgraded to Equal Weight from Overweight at Barclays
09/30/21 Cowen
Acceleron downgraded to Market Perform from Outperform at Cowen
BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

10/26/21 RBC Capital
Aurinia Pharmaceuticals price target raised to $34 from $23 at RBC Capital
10/25/21 SVB Leerink
Potential Bristol takeover of Aurinia makes strategic sense, says SVB Leerink
10/25/21 Citi
Bristol-Myers report of Aurinia approach 'looks credible,' says Citi
10/12/21 Morgan Stanley
Bristol-Myers price target lowered to $66 from $71 at Morgan Stanley
XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

XLRN Acceleron
$173.85 /

+0.23 (+0.13%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

BMY Bristol-Myers
$58.24 /

+0.47 (+0.81%)

Earnings
Silicon Labs sees Q4 non-GAAP EPS50c-60c , consensus 19c » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
SLAB

Silicon Labs

$154.95 /

+0.69 (+0.45%)

Sees Q4 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

10/19/21 Stifel
Ambarella price target raised to $185 from $145 at Stifel
05/19/21
Fly Intel: Top five analyst downgrades
05/19/21 Citi
Silicon Labs downgraded to Neutral from Buy at Citi
04/29/21 JPMorgan
Silicon Labs downgraded to Neutral on valuation at JPMorgan
SLAB Silicon Labs
$154.95 /

+0.69 (+0.45%)

Earnings
GlaxoSmithKline raises 2021 EPS guidance, confirms 2022 outlook » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
GSK

GlaxoSmithKline

$40.18 /

+0.375 (+0.94%)

Glaxo said: "GSK now…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

10/18/21 Berenberg
GlaxoSmithKline price target lowered to 1,540 GBp from 1,625 GBp at Berenberg
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/07/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,555 GBp at Morgan Stanley
10/04/21 Alliance Global Partners
Achieve Life Sciences initiated with a Buy at Alliance Global Partners
GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

GSK GlaxoSmithKline
$40.18 /

+0.375 (+0.94%)

Earnings
Sharps Compliance reports Q1 EPS (4c), consensus (3c) » 07:16
10/27/21
10/27
07:16
10/27/21
07:16
SMED

Sharps Compliance

$8.02 /

-0.18 (-2.20%)

Reports Q1 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMED Sharps Compliance
$8.02 /

-0.18 (-2.20%)

SMED Sharps Compliance
$8.02 /

-0.18 (-2.20%)

08/20/21 Barrington
Sharps Compliance price target lowered to $13 from $18 at Barrington
05/06/21 Barrington
Sharps Compliance price target raised to $18 from $15 at Barrington
04/29/21 H.C. Wainwright
Sharps Compliance price target raised to $25 from $18 at H.C. Wainwright
03/23/21 Roth Capital
Sharps Compliance target raised to $16 at Roth Capital on Mailback strength
SMED Sharps Compliance
$8.02 /

-0.18 (-2.20%)

  • 26
    Aug

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.